ELAB vs FCX · rev $2.0M vs P/E 38, rev $13.26B
Elevai Labs, Inc. Common Stock (ELAB) versus Freeport-McMoran Copper & Gold Inc (FCX) — a side-by-side from cached financials, not a winner call.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
Freeport-McMoran Copper & Gold Inc (FCX) is a copper company listed on US.
Latest reported ELAB revenue for 2026-06-30 was $2.0M. Net income was -$7.9M. ELAB currently screens at market cap $6.5M.
Latest reported FCX revenue for 2026-06-30 was $13.26B. Net income was $1.86B. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
ELAB currently screens at market cap $6.5M. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
Not investment advice. Open the ELAB and FCX stock pages for the full models.
Not investment advice.